Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
NTRA
NTRA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NTRA News
Natera (NTRA.US) Officer Plans to Sell $3.31 Million in Common Stock via Form 144
3d ago
moomoo
Exelixis Aims to Expand Beyond Cabozantinib Franchise
Feb 28 2026
NASDAQ.COM
Exelixis Aims to Become a Top Oncology Player with Expanding Pipeline
Feb 28 2026
Fool
Signatera MRD Enhances Quality of Life in Genitourinary Cancers
Feb 27 2026
Newsfilter
Natera Reports Record Q4 2025 Earnings with Strong Growth
Feb 27 2026
seekingalpha
Natera (NTRA) Q4 2025 Earnings Call Transcript
Feb 27 2026
NASDAQ.COM
Natera's Phase 2 Study of Signatera ctDNA Test Announced
Feb 24 2026
Yahoo Finance
SINERGY Trial Validates Signatera Treatment Approach with High Response Rate
Feb 24 2026
Newsfilter
Stanley Druckenmiller's Investment Portfolio Insights
Feb 22 2026
Fool
Natera's Growth Potential and TSMC's AI Demand Challenges
Feb 22 2026
NASDAQ.COM
Stanley Druckenmiller Bets Big on These 2 Stocks
Feb 22 2026
Yahoo Finance
Natera Announces Q4 and Full Year 2025 Earnings Release Date
Feb 17 2026
Newsfilter
Natera Launches Large-Scale Prenatal Screening Study
Feb 06 2026
Newsfilter
Natera Inc Shares Show Oversold Signal
Feb 04 2026
NASDAQ.COM
Natera Submits PMA for MRD Detection in Bladder Cancer
Feb 02 2026
Newsfilter
Stan Druckenmiller: The Influential Figure Behind Bessent and Warsh, Potential Candidates for Fed Chair
Feb 02 2026
Barron's
Show More News
